ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
Dow Jones
42,840.26
1.18%
US Dollar vs MXN
20.0813
0.00%
Brent Oil
72.72
0.00%
Bitcoin
96,613.31
-0.61%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Canadá
  5. TSX
  6. VIVO Cannabis Inc (LABS)

  7. VIVO Cannabis Inc (LABS) Noticias

LABS

VIVO Cannabis (LABS)

VIVO Cannabis Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:TSX:LABS
FechaHoraFuenteTítuloSímboloCompañía
17/12/202406:29PR Newswire (US)MediPharm Labs to Sell its Napanee Facility to Kensana Health for $5.5MTSX:LABSVIVO Cannabis Inc
14/11/202406:00PR Newswire (US)MediPharm Labs Reports Third Quarter ResultsTSX:LABSVIVO Cannabis Inc
11/11/202405:15PR Newswire (US)MediPharm Labs Sets Date to Report Third Quarter 2024 Financial ResultsTSX:LABSVIVO Cannabis Inc
17/10/202406:35PR Newswire (Canada)MediPharm Labs Announces Departure of President and Co-Founder Keith StrachanTSX:LABSVIVO Cannabis Inc
17/09/202405:45PR Newswire (Canada)MediPharm Labs Announces $2.1M Debt RepaymentTSX:LABSVIVO Cannabis Inc
14/08/202406:00PR Newswire (US)MediPharm Labs Reports Second Quarter Results Closing in on Positive Adjusted EBITDA(1) as Gross Profit Continues to ImproveTSX:LABSVIVO Cannabis Inc
13/08/202407:00PR Newswire (US)/R E P E A T -- MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results/TSX:LABSVIVO Cannabis Inc
08/08/202415:30PR Newswire (US)MediPharm Labs Sets Date to Report Second Quarter 2024 Financial ResultsTSX:LABSVIVO Cannabis Inc
26/06/202416:15PR Newswire (US)MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of ShareholdersTSX:LABSVIVO Cannabis Inc
20/06/202405:45PR Newswire (US)MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose AerosolsTSX:LABSVIVO Cannabis Inc
15/05/202405:15PR Newswire (Canada)MediPharm Labs Reports First Quarter ResultsTSX:LABSVIVO Cannabis Inc
08/05/202415:30PR Newswire (US)MediPharm Labs Sets Date to Report First Quarter 2024 Financial ResultsTSX:LABSVIVO Cannabis Inc
27/03/202409:54PR Newswire (Canada)MediPharm Labs Provides Conference Call Recording DetailsTSX:LABSVIVO Cannabis Inc
27/03/202405:30PR Newswire (Canada)MediPharm Labs Reports Fourth Quarter and Full Year ResultsTSX:LABSVIVO Cannabis Inc
25/03/202405:30PR Newswire (Canada)MediPharm Labs Provides Update on German Cannabis LegalizationTSX:LABSVIVO Cannabis Inc
22/03/202405:30PR Newswire (US)MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2023 Financial ResultsTSX:LABSVIVO Cannabis Inc
07/02/202405:30PR Newswire (US)MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health AuthorityTSX:LABSVIVO Cannabis Inc
22/12/202306:00PR Newswire (US)MediPharm Labs Provides Update on Board of Directors and Long Term Incentive ProgramTSX:LABSVIVO Cannabis Inc
08/11/202316:01PR Newswire (Canada)MediPharm Labs Sets Date to Report Third Quarter 2023 Financial ResultsTSX:LABSVIVO Cannabis Inc
25/10/202306:00PR Newswire (US)MediPharm Labs Update on $9M Settlement Agreement - All Tilray Shares Sold and Converted to CashTSX:LABSVIVO Cannabis Inc
02/10/202306:00PR Newswire (US)MediPharm Labs Settles an Outstanding Claim for $9MTSX:LABSVIVO Cannabis Inc
27/09/202306:15PR Newswire (Canada)MediPharm Labs Launches new GMP Products to the Australian Medical Cannabis MarketTSX:LABSVIVO Cannabis Inc
20/09/202306:00PR Newswire (US)MediPharm Labs Improves Domestic Sales Gross Margin with Termination of Shelter Cannabis Brands Royalty AgreementTSX:LABSVIVO Cannabis Inc
05/09/202306:39PR Newswire (US)MediPharm Labs Completes Sale of Vacant Land for Cash Proceeds of $1.9 millionTSX:LABSVIVO Cannabis Inc
31/08/202307:02PR Newswire (US)MediPharm Labs Publishes Study Investigating Medical Cannabis Impacts on Anxiety and Depression Outcomes in Fibromyalgia PatientsTSX:LABSVIVO Cannabis Inc
14/08/202306:13PR Newswire (Canada)MediPharm Labs Reports Second Quarter Results with Doubling of Revenue and Record Margin GrowthTSX:LABSVIVO Cannabis Inc
10/08/202316:00PR Newswire (US)MediPharm Labs Sets Date to Report Second Quarter 2023 Financial ResultsTSX:LABSVIVO Cannabis Inc
01/08/202306:00PR Newswire (US)MediPharm Labs Makes First Delivery of Cannabis Clinical Trial Material to US Research Partner and Provides Update on US FDA StatusTSX:LABSVIVO Cannabis Inc
22/06/202316:50PR Newswire (Canada)MediPharm Labs Announces Change of AuditorTSX:LABSVIVO Cannabis Inc
15/05/202306:07PR Newswire (Canada)MediPharm Labs Reports First Quarter Results with Growth in Sales, Margin and EBITDATSX:LABSVIVO Cannabis Inc
 Showing the most relevant articles for your search:TSX:LABS

Su Consulta Reciente

NASDAQ
FZEFUX
American Recovery Portfo...
NASDAQ
CFJLX
Ci Mosaic Income Etf Por...
NASDAQ
CDPYX
Ci Global Equity & Incom...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados